Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FDC5T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,344
Award facts
- Contract value 100% obligated
- $38,343.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $38,343.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 29, 2026, for the supply of Zepbound 7.5 mg/0.5 ml pens. The contract, which is not set-aside and was competitively awarded, has an ultimate completion date of January 30, 2026, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen's role as a major pharmaceutical distributor positions it as a critical vendor in the federal medical procurement supply chain, supplying an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to military treatment facilities and other government healthcare systems. The delivery of Zepbound, a diabetes medication, reflects the company's ongoing capability to fulfill specialized pharmaceutical requirements for federal agencies, consistent with its established track record of competitive awards and efficient contract performance across diverse medical commodity categories.
Quick answers
Who was awarded contract SPE2DR26FDC5T?
SPE2DR26FDC5T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FDC5T worth?
The government has obligated $38,344 on SPE2DR26FDC5T.
Is contract SPE2DR26FDC5T an order under another contract?
Yes. SPE2DR26FDC5T is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FDC5T competed?
The extent of competition for SPE2DR26FDC5T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award